Ron Gill

Ron is the CTO of Xsensio, where he leads the development of the company’s proprietary Lab-on-Skin™ sensing platform. He holds a PhD in Chemistry, B.Sc in Materials Engineering and a B.A. in Physics. Before joining Xsensio, he spent several years developing novel biosensing concepts as an assistant professor at the University of Twente in the Netherlands and then moved to industry and worked as the CTO of the Dutch start up Biovolt BV, where he was managing the technology development of diagnostics assays for metabolic syndrome related health issues. Xsensio SA is a swiss start-up that develops innovative wearable systems that continuously monitor our physiological state to detect risks in real-time.